Xebec Adsorption Inc. (TSX: XBC) (“Xebec”), a
global provider of clean energy solutions, is pleased to announce
today that its wholly owned subsidiary Inmatec, has received an
order for 14 POC medical on-site oxygen generators for hospitals in
Moldova. This contract follows a number of recent orders including
one placed in December 2020 for 48 units, valued at €1.7 million,
for hospitals in India. In addition, Inmatec has completed a number
of high-profile deliveries to healthcare facilities in Peru, United
Kingdom, Africa and the Middle East.
Medical oxygen has seen surging demand as a
result of the worldwide COVID-19 pandemic. Oxygen is used by
patients with severe symptoms of COVID-19, in addition in patients
requiring oxygen for other disease states such as chronic
obstructive pulmonary disease (COPD), cystic fibrosis (CF) and
asthma. As a result of the new demand, supply bottlenecks for the
gas have been created and this has showcased the challenges with
securing oxygen from centralized sources.
Xebec is supporting the fight against COVID-19
with its on-site oxygen generation products, which improve the
supply and delivery constraints by providing an economical means
for on-site production. By adopting these products, hospitals get
access to immediate, stable production at up to 60% lower cost and
lower carbon emissions than traditional supply options.
“We are proud to be playing our part in fighting
the novel coronavirus. Oxygen shortages continue to be rampant
around the world in both developed and developing countries. Most
importantly, Inmatec enables remote hospitals to have economical
access to oxygen for patients on ventilators, in operating theatres
under anesthesia, and to fill cylinders. This same technology
platform can also be applied for fish farming, wastewater treatment
and renewable natural gas production. Xebec is becoming a key
player in distributed gas generation with an aim to lower costs and
emissions for customers,” stated Marinus van Driel, President of
Xebec Europe.
2020 saw an accelerated adoption of
medical on-site oxygen generationIn response to the
pandemic, numerous governments implemented measures, adjusted
regulations or made direct investments to secure adequate oxygen
production. As a result of the improved backdrop, Inmatec delivered
224 oxygen generators in 2020, up from 118 in the previous year,
resulting in revenue more than tripling. Xebec expects that
customers around the world will continue to recognize the benefits
of on-site oxygen generation and consequently has delivered (as of
March 22, 2021) 66 units in 2021 to customers around the globe and
has received orders for another 67 units.
Related
links:https://www.xebecinc.comhttps://www.inmatec.de/en/startsite.htmlhttps://www.inmatec.de/en/news-stories-details/oxygen-generator-provides-improved-medical-care-at-st-kizito-hospital-in-uganda.html
Media Inquiries:Public Relations for
XebecVictor Henriquez, Senior
Partnervictor@publicsc.com+1 514.377.1102
Investor Relations:Xebec
Adsorption Inc.Brandon Chow, Director, Investor
Relationsbchow@xebecinc.com+1 450.979.8700 ext 5762
About Xebec Adsorption
Inc.Xebec is a global provider of clean energy solutions
for renewable and low carbon gases used in energy, mobility and
industry applications. The company specializes in deploying a
portfolio of proprietary technologies for the distributed
production of hydrogen, renewable natural gas, oxygen and nitrogen.
By focusing on environmentally responsible gas generation, Xebec
has helped thousands of customers around the world reduce their
carbon footprints and operating costs. Headquartered in Québec,
Canada, Xebec has a worldwide presence with five manufacturing
facilities, eight Cleantech Service Centers and four sales offices
spanning over four continents. Xebec trades on the Toronto Stock
Exchange under the symbol (TSX: XBC). For more
information, xebecinc.com.
Cautionary Statement This news
release contains forward-looking statements and forward-looking
information (together, “forward-looking statements”) within the
meaning of applicable securities laws. All statements, other than
statements of historical facts, are forward-looking statements, and
subject to risks and uncertainties. Generally, forward-looking
statements can be identified by the use of terminology such as
“plans”, “seeks”, “expects”, “estimates”, “intends”, “anticipates”,
“believes”, “could”, “might”, “likely” or variations of such words,
or statements that certain actions, events or results “may”,
“will”, “could”, “would”, “might”, “will be taken”, “occur”, “be
achieved” or other similar expressions. Forward-looking statements,
including statements concerning future capital expenditures,
revenues, expenses, earnings, economic performance, indebtedness,
financial condition, losses and future prospects as well as the
expectations of management of Xebec with respect to information
regarding the business and the expansion and growth of Xebec
operations, involve risks, uncertainties and other factors that
could cause actual results, performance, prospects and
opportunities to differ materially from those expressed or implied
by such forward-looking statements. Forward-looking statements are
subject to business and economic factors and uncertainties, and
other factors that could cause actual results to differ materially
from these forward-looking statements, including the relevant
assumptions and risks factors set out in Xebec's public documents,
including in the most recent annual management discussion and
analysis and annual information form, filed on SEDAR at
www.sedar.com. Furthermore, should one or more of the risks,
uncertainties or other factors materialize, or should underlying
assumptions prove incorrect, actual results may vary materially
from those described in forward-looking statements or information.
These risks, uncertainties and other factors include, among others,
the uncertain and unpredictable condition of global economy,
notably as a consequence of the Covid-19 pandemic, Xebec’s capacity
to generate revenue growth, the availability to Xebec of financing
and credit alternatives and access to capital, Xebec’s capacity to
meet all its other commitments and business plans, Xebec’s limited
number of customers, the potential loss of key employees, changes
in the use of proceeds relating to the loan, share price
volatility, and other factors. Although Xebec believes that the
assumptions and factors used in preparing the forward-looking
statements are reasonable, undue reliance should not be placed on
these statements, which only apply as of the date of this news
release, and no assurance can be given that such events will occur
in the disclosed times frames or at all. Except where required by
applicable law, Xebec disclaims any intention or obligation to
update or revise any forward-looking statement, whether as a result
of new information, future events or otherwise.
Xebec Adsorption (TSX:XBC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Xebec Adsorption (TSX:XBC)
Historical Stock Chart
From Apr 2023 to Apr 2024